Authors
Loading...
This platform detects circulating tumor DNA mutations in point-of-care testing, indicating full clinical concordance with diagnoses.
Ming et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: